My Quote Request
No products added yet
6505-00-114-8985
20 Products
X-1281
CODEINE SULFATE TABLETS,USP
NSN, MFG P/N
6505001148985
NSN
6505-00-114-8985
MFG
VETERANS ADMINISTRATION SPECIFICATIONS PROMULGATED BY VETERANS ADMINISTRATION WASHINGTON DC
Description
ADMINISTRATION: ORAL
DEFINITIVE GOVERNMENT SPEC/STD REFERENCE: X-1281
MANUFACTURERS CODE: 24065
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPEC/STD CONTROLLING DATA:
SPECIAL FEATURES: ACTIVE MEDICANT MEDICINAL STRENGTH EACH TABLET 30 TO 32 MG OF CODEINE SULFATE NF WITHIN THE DESIGNATED ASSAY LIMITS
Related Searches:
NDC60432-0741-15
ACETIC ACID OTIC SOLUTION,USP
NSN, MFG P/N
6505001117864
NSN
6505-00-111-7864
NDC60432-0741-15
ACETIC ACID OTIC SOLUTION,USP
NSN, MFG P/N
6505001117864
NSN
6505-00-111-7864
MFG
MORTON GROVE PHARMACEUTICALS INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETIC ACID OTIC SOLUTION USP 15 ML BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
VOSOL
ACETIC ACID OTIC SOLUTION,USP
NSN, MFG P/N
6505001117864
NSN
6505-00-111-7864
MFG
WAMPOLE LABORATORIES DIV OF CARTER-WALLACE INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETIC ACID OTIC SOLUTION USP 15 ML BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC66591-0641-51
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505001118359
NSN
6505-00-111-8359
NDC66591-0641-51
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505001118359
NSN
6505-00-111-8359
MFG
AAIPHARMA INC DBA A A I
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 650.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT AND 100.000 MILLIGRAMS PROPOXYPHENE NAPSYLATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROPOXYPHENE NAPSYLATE & ACETAMINOPHEN TABLETS USP 500 TABLETS/BOTTLES
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
DARVOCET-N
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505001118373
NSN
6505-00-111-8373
DARVOCET-N
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505001118373
NSN
6505-00-111-8373
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 650.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT AND 100.000 MILLIGRAMS PROPOXYPHENE NAPSYLATE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROPOXYPHENE NAPSYLATE & ACETAMINOPHEN TABLETS USP I.S. 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
Related Searches:
DARVOCET-N TABLETS
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505001118373
NSN
6505-00-111-8373
DARVOCET-N TABLETS
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505001118373
NSN
6505-00-111-8373
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 650.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT AND 100.000 MILLIGRAMS PROPOXYPHENE NAPSYLATE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROPOXYPHENE NAPSYLATE & ACETAMINOPHEN TABLETS USP I.S. 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
Related Searches:
NDC00002-0363-33
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505001118373
NSN
6505-00-111-8373
NDC00002-0363-33
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505001118373
NSN
6505-00-111-8373
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 650.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT AND 100.000 MILLIGRAMS PROPOXYPHENE NAPSYLATE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROPOXYPHENE NAPSYLATE & ACETAMINOPHEN TABLETS USP I.S. 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
Related Searches:
NDC00182-0317-89
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505001118373
NSN
6505-00-111-8373
NDC00182-0317-89
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505001118373
NSN
6505-00-111-8373
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 650.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT AND 100.000 MILLIGRAMS PROPOXYPHENE NAPSYLATE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROPOXYPHENE NAPSYLATE & ACETAMINOPHEN TABLETS USP I.S. 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
Related Searches:
UC115
CAPSULE,GELATIN
NSN, MFG P/N
6505001124511
NSN
6505-00-112-4511
MFG
FEDERAL SPECIFICATIONS PROMULGATED BY GENERAL SERVICES ADMINISTRATION WASHINGTON DC
Description
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.010 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.11 POUNDS
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
MANUFACTURERS CODE: 81348
NON-DEFINITIVE GOVERNMENT SPEC/STD REFERENCE: UC115
PRIMARY CONTAINER TYPE: BOX
SPEC/STD CONTROLLING DATA:
SPECIAL FEATURES: SIZE DESIGNATOR-1,COLOR-COLORLESS,SHAPE-CYLINDRICAL
SUPPLEMENTARY FEATURES: EMPTY
Related Searches:
UC115
CAPSULE,GELATIN
NSN, MFG P/N
6505001124512
NSN
6505-00-112-4512
MFG
FEDERAL SPECIFICATIONS PROMULGATED BY GENERAL SERVICES ADMINISTRATION WASHINGTON DC
Description
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.010 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.08 POUNDS
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
MANUFACTURERS CODE: 81348
NON-DEFINITIVE GOVERNMENT SPEC/STD REFERENCE: UC115
PRIMARY CONTAINER TYPE: BOX
SPEC/STD CONTROLLING DATA:
SPECIAL FEATURES: SIZE DESIGNATOR-2,COLOR-COLORLESS,SHAPE-CYLINDRICAL
SUPPLEMENTARY FEATURES: EMPTY
Related Searches:
005339
CITRIC ACID,USP
NSN, MFG P/N
6505001142510
NSN
6505-00-114-2510
MFG
GALLIPOT INC. DBA GALLIPOT LABS
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CITRIC ACID USP GRANULE FORM 453.6 GM OR 1 LB
PHYSICAL FORM: GRANULE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 POUNDS OR 453.600 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: HYDROUS FORM CONTAINING ONE MOLECULE OF WATER OF HYDRATION
Related Searches:
NDC17137-0116-01
CITRIC ACID,USP
NSN, MFG P/N
6505001142510
NSN
6505-00-114-2510
MFG
AMEND DRUG AND CHEMICAL CO
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CITRIC ACID USP GRANULE FORM 453.6 GM OR 1 LB
PHYSICAL FORM: GRANULE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 POUNDS OR 453.600 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: HYDROUS FORM CONTAINING ONE MOLECULE OF WATER OF HYDRATION
Related Searches:
811/12000 MOYCO
COAL TAR TOPICAL SOLUTION,USP
NSN, MFG P/N
6505001143010
NSN
6505-00-114-3010
811/12000 MOYCO
COAL TAR TOPICAL SOLUTION,USP
NSN, MFG P/N
6505001143010
NSN
6505-00-114-3010
MFG
MOYCO INDUSTRIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, V/V TAR, COAL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: COAL TAR TOPICAL SOLUTION USP 20% 1 PT OR 473 ML BOTTLE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 PINTS OR 473.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC17137-0123-01
COAL TAR TOPICAL SOLUTION,USP
NSN, MFG P/N
6505001143010
NSN
6505-00-114-3010
NDC17137-0123-01
COAL TAR TOPICAL SOLUTION,USP
NSN, MFG P/N
6505001143010
NSN
6505-00-114-3010
MFG
AMEND DRUG AND CHEMICAL CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, V/V TAR, COAL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: COAL TAR TOPICAL SOLUTION USP 20% 1 PT OR 473 ML BOTTLE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 PINTS OR 473.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
0074-02
COLCHICINE TABLETS,USP
NSN, MFG P/N
6505001149700
NSN
6505-00-114-9700
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLIGRAMS COLCHICINE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00074-0074-02
COLCHICINE TABLETS,USP
NSN, MFG P/N
6505001149700
NSN
6505-00-114-9700
NDC00074-0074-02
COLCHICINE TABLETS,USP
NSN, MFG P/N
6505001149700
NSN
6505-00-114-9700
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLIGRAMS COLCHICINE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
XYL0CAINE
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505001150052
NSN
6505-00-115-0052
XYL0CAINE
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505001150052
NSN
6505-00-115-0052
MFG
ASTRA PHARMACEUTICALS LP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
EURAX
CROTAMITON CREAM,USP
NSN, MFG P/N
6505001160200
NSN
6505-00-116-0200
MFG
BRISTOL-MYERS SQUIBB CO WESTWOOD-SQUIBB PHARMACEUTICALS DIV
Description
ACTIVE INGREDIENT AND STRENGTH: 10.000 CROTAMITON PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CROTAMITON CREAM USP 10% 60 GM
MEDICAMENT BASE TYPE: VANISHING CREAM
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
Related Searches:
NDC00072-2103-60
CROTAMITON CREAM,USP
NSN, MFG P/N
6505001160200
NSN
6505-00-116-0200
NDC00072-2103-60
CROTAMITON CREAM,USP
NSN, MFG P/N
6505001160200
NSN
6505-00-116-0200
MFG
CARDINAL HEALTH 200 LLC
Description
ACTIVE INGREDIENT AND STRENGTH: 10.000 CROTAMITON PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CROTAMITON CREAM USP 10% 60 GM
MEDICAMENT BASE TYPE: VANISHING CREAM
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
Related Searches:
KLORVESS
POTASSIUM CHLORIDE,LYSINE HYDROCHLORIDE,AND POTASSIUM BICARBONATE EFFERVESCENT TABLETS FOR ORAL SOLUTION
NSN, MFG P/N
6505001160604
NSN
6505-00-116-0604
KLORVESS
POTASSIUM CHLORIDE,LYSINE HYDROCHLORIDE,AND POTASSIUM BICARBONATE EFFERVESCENT TABLETS FOR ORAL SOLUTION
NSN, MFG P/N
6505001160604
NSN
6505-00-116-0604
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.913 GRAMS LYSINE HYDROCHLORIDE ACTIVE INGREDIENT AND 0.500 GRAMS POTASSIUM BICARBONATE ACTIVE INGREDIENT AND 1.125 GRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE LYSINE HYDROCHLORIDE 1 DOSE 20MEQ 60S
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 1 DOSE SUPPLIES 20 MEQ EACH OF POTASSIUM AND CHLORIDE; INDIVIDUALLY SEALED IN ALUMINUM FOIL PACKETS; BOX OF 60 CONTAINS 2 UNITS OF 30
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
